These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8228337)

  • 1. Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role.
    Verrando P; Schofield O; Ishida-Yamamoto A; Aberdam D; Partouche O; Eady RA; Ortonne JP
    J Invest Dermatol; 1993 Nov; 101(5):738-43. PubMed ID: 8228337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression.
    Baudoin C; Miquel C; Blanchet-Bardon C; Gambini C; Meneguzzi G; Ortonne JP
    J Clin Invest; 1994 Feb; 93(2):862-9. PubMed ID: 8113417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basement membrane proteins kalinin and nicein are structurally and immunologically identical.
    Marinkovich MP; Verrando P; Keene DR; Meneguzzi G; Lunstrum GP; Ortonne JP; Burgeson RE
    Lab Invest; 1993 Sep; 69(3):295-9. PubMed ID: 8377472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin.
    Verrando P; Lissitzky JC; Sarret Y; Winberg JO; Gedde-Dahl T; Schmitt D; Bruckner-Tuderman L
    Lab Invest; 1994 Oct; 71(4):567-74. PubMed ID: 7967512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients.
    Meneguzzi G; Marinkovich MP; Aberdam D; Pisani A; Burgeson R; Ortonne JP
    Exp Dermatol; 1992 Dec; 1(5):221-9. PubMed ID: 1365323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 6/2 (AA3) polyclonal antibody identifying a 37 kD keratinocyte protein reacts also with BM-600/nicein, the basement membrane component bound by the monoclonal antibody GB3.
    Verrando P; Partouche O; Pisani A; Ortonne JP
    Exp Dermatol; 1992 Jul; 1(1):52-8. PubMed ID: 1344661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study.
    Schofield OM; Fine JD; Verrando P; Heagerty AH; Ortonne JP; Eady RA
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1078-83. PubMed ID: 2273105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa.
    Verrando P; Blanchet-Bardon C; Pisani A; Thomas L; Cambazard F; Eady RA; Schofield O; Ortonne JP
    Lab Invest; 1991 Jan; 64(1):85-92. PubMed ID: 1990210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of a new antigen of the dermal-epidermal junction (NU-T2 DEJ Ag) in junctional epidermolysis bullosa.
    Tadini G; Kanitakis J; Cavalli R; Schmitt D; Cambiaghi S; Berti E
    Arch Dermatol Res; 1995; 287(8):699-704. PubMed ID: 8554379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa.
    Phillips RJ; Aplin JD; Lake BD
    Histopathology; 1994 Jun; 24(6):571-6. PubMed ID: 8063286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal junctional epidermolysis bullosa with normal expression of BM 600 and antro-pyloric atresia: a new variant of junctional epidermolysis bullosa?
    Lacour JP; Hoffman P; Bastiani-Griffet F; Boutte P; Pisani A; Ortonne JP
    Eur J Pediatr; 1992 Apr; 151(4):252-7. PubMed ID: 1499575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of Herlitz junctional epidermolysis bullosa by amniocentesis.
    Marinkovich MP; Meneguzzi G; Burgeson RE; Blanchet-Bardon C; Holbrook KA; Smith LT; Christiano AM; Ortonne JP
    Prenat Diagn; 1995 Nov; 15(11):1027-34. PubMed ID: 8606881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa.
    Jonkman MF; de Jong MC; Heeres K; Sonnenberg A
    J Invest Dermatol; 1992 Oct; 99(4):489-96. PubMed ID: 1402007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia.
    Brown TA; Gil SG; Sybert VP; Lestringant GG; Tadini G; Caputo R; Carter WG
    J Invest Dermatol; 1996 Sep; 107(3):384-91. PubMed ID: 8751975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctional epidermolysis bullosis: defects in expression of epiligrin/nicein/kalinin and integrin beta 4 that inhibit hemidesmosome formation.
    Gil SG; Brown TA; Ryan MC; Carter WG
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):31S-38S. PubMed ID: 7963682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of the integrin beta 4 subunit in junctional epidermolysis bullosa with pyloric atresia: consequences for hemidesmosome formation and adhesion properties.
    Niessen CM; van der Raaij-Helmer MH; Hulsman EH; van der Neut R; Jonkman MF; Sonnenberg A
    J Cell Sci; 1996 Jul; 109 ( Pt 7)():1695-706. PubMed ID: 8832392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.
    Kirtschig G; Marinkovich MP; Burgeson RE; Yancey KB
    J Invest Dermatol; 1995 Oct; 105(4):543-8. PubMed ID: 7561156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
    Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exclusion of pyloric atresia-junctional epidermolysis bullosa syndrome.
    Shimizu H; Fine JD; Suzumori K; Hatta N; Shozu M; Nishikawa T
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):429-33. PubMed ID: 8077467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.